CCR6 regulates CD4+ T-cell-mediated acute graft-versus-host disease responses.
暂无分享,去创建一个
[1] M. Fishbein,et al. Chemokine Monokine Induced by IFN-γ/CXC Chemokine Ligand 9 Stimulates T Lymphocyte Proliferation and Effector Cytokine Production1 , 2004, The Journal of Immunology.
[2] J. Flores,et al. CCR6 has a non‐redundant role in the development of inflammatory bowel disease , 2003, European journal of immunology.
[3] J. Van Damme,et al. The CC chemokine CCL20 and its receptor CCR6. , 2003, Cytokine & growth factor reviews.
[4] S. Clouthier,et al. Role of CXCR3-induced donor T-cell migration in acute GVHD. , 2003, Experimental hematology.
[5] D. Danilenko,et al. The role of interferon‐γ, nitric oxide and lipopolysaccharide in intestinal graft‐versus‐host disease developing in F1‐hybrid mice , 2003 .
[6] M. Suematsu,et al. Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction , 2003, Nature Immunology.
[7] S. Fujita,et al. Antagonist of Secondary Lymphoid-Tissue Chemokine (CCR Ligand 21) Prevents the Development of Chronic Graft-Versus-Host Disease in Mice1 , 2003, The Journal of Immunology.
[8] L. Mayer,et al. Colonic epithelial cells are a major site of macrophage inflammatory protein 3α (MIP-3α) production in normal colon and inflammatory bowel disease , 2002, Gut.
[9] C. Thoburn,et al. Cytokine and chemokine profiles in autologous graft-versus-host disease (GVHD): interleukin 10 and interferon gamma may be critical mediators for the development of autologous GVHD. , 2002, Blood.
[10] Derek D. Yang,et al. Accelerated Onset and Increased Severity of Acute Graft-Versus-Host Disease Following Adoptive Transfer of DR6-Deficient T Cells , 2002, The Journal of Immunology.
[11] L. McCormick,et al. Murine Sclerodermatous Graft-Versus-Host Disease, a Model for Human Scleroderma: Cutaneous Cytokines, Chemokines, and Immune Cell Activation1 , 2002, The Journal of Immunology.
[12] H. Soto,et al. CCL27–CCR10 interactions regulate T cell–mediated skin inflammation , 2002, Nature Medicine.
[13] Lisa M. Ebert,et al. Up-Regulation of CCR5 and CCR6 on Distinct Subpopulations of Antigen-Activated CD4+ T Lymphocytes1 , 2002, The Journal of Immunology.
[14] R. Soiffer,et al. The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. , 2001, Blood.
[15] James J. Campbell,et al. CC Chemokine Receptor (CCR)4 and the CCR10 Ligand Cutaneous T Cell–attracting Chemokine (CTACK) in Lymphocyte Trafficking to Inflamed Skin , 2001, The Journal of experimental medicine.
[16] O. Yoshie,et al. Proinflammatory cytokines induce liver and activation-regulated chemokine/macrophage inflammatory protein-3α/CCL20 in mucosal epithelial cells through NF-κB , 2001 .
[17] J. Antin. Acute graft-versus-host disease: inflammation run amok? , 2001 .
[18] D. Snider,et al. Early Intestinal Th1 Inflammation and Mucosal T Cell Recruitment During Acute Graft-Versus-Host Reaction1 , 2001, The Journal of Immunology.
[19] M. Leach,et al. Characterization of chemokines and chemokine receptors in two murine models of inflammatory bowel disease: IL‐10– / – mice and Rag‐2– / – mice reconstituted with CD4+CD45RBhigh T cells , 2001, European journal of immunology.
[20] M. Kagnoff,et al. Regulated MIP-3alpha/CCL20 production by human intestinal epithelium: mechanism for modulating mucosal immunity. , 2001, American journal of physiology. Gastrointestinal and liver physiology.
[21] C. Martínez-A,et al. CCR6-deficient mice have impaired leukocyte homeostasis and altered contact hypersensitivity and delayed-type hypersensitivity responses. , 2001, The Journal of clinical investigation.
[22] T. Tezuka,et al. Inducible expression of a CC chemokine liver- and activation-regulated chemokine (LARC)/macrophage inflammatory protein (MIP)-3 alpha/CCL20 by epidermal keratinocytes and its role in atopic dermatitis. , 2001, International immunology.
[23] S. Caughman,et al. Cutting Edge: C-C Chemokine Receptor 6 Is Essential for Arrest of a Subset of Memory T Cells on Activated Dermal Microvascular Endothelial Cells Under Physiologic Flow Conditions In Vitro , 2000, The Journal of Immunology.
[24] J. Serody,et al. T-lymphocyte production of macrophage inflammatory protein-1α is critical to the recruitment of CD8+ T cells to the liver, lung, and spleen during graft-versus-host disease , 2000 .
[25] S. Targan,et al. The Role of Thymus-Expressed Chemokine and Its Receptor CCR9 on Lymphocytes in the Regional Specialization of the Mucosal Immune System1 , 2000, The Journal of Immunology.
[26] C. Caux,et al. Macrophage Inflammatory Protein 3α Is Expressed at Inflamed Epithelial Surfaces and Is the Most Potent Chemokine Known in Attracting Langerhans Cell Precursors , 2000, The Journal of experimental medicine.
[27] C. Caux,et al. Up-Regulation of Macrophage Inflammatory Protein-3α/CCL20 and CC Chemokine Receptor 6 in Psoriasis1 , 2000, The Journal of Immunology.
[28] H. Greenberg,et al. CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. , 2000, Immunity.
[29] A. Iwasaki,et al. Localization of Distinct Peyer's Patch Dendritic Cell Subsets and Their Recruitment by Chemokines Macrophage Inflammatory Protein (Mip)-3α, Mip-3β, and Secondary Lymphoid Organ Chemokine , 2000, The Journal of experimental medicine.
[30] F. Sallusto,et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.
[31] M. Shlomchik,et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. , 1999, Science.
[32] K. Matsushima,et al. Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease. , 1999, The Journal of clinical investigation.
[33] Y. Tanaka,et al. Selective expression of liver and activation‐regulated chemokine (LARC) in intestinal epithelium in mice and humans , 1999, European journal of immunology.
[34] R. Rabin,et al. CC-Chemokine Receptor 6 Is Expressed on Diverse Memory Subsets of T Cells and Determines Responsiveness to Macrophage Inflammatory Protein 3α , 1999, The Journal of Immunology.
[35] Á. Zaballos,et al. Molecular cloning, functional characterization and mRNA expression analysis of the murine chemokine receptor CCR6 and its specific ligand MIP‐3α 1 , 1998 .
[36] K. HayGlass,et al. Murine graft-versus-host disease in an F1-hybrid model using IFN-gamma gene knockout donors. , 1998, Journal of immunology.
[37] E. Butcher,et al. Chemokines and the arrest of lymphocytes rolling under flow conditions. , 1998, Science.
[38] M. Detmar,et al. Murine psoriasis-like disorder induced by naive CD4+ T cells , 1997, Nature Medicine.
[39] A. B. Lyons,et al. Determination of lymphocyte division by flow cytometry. , 1994, Journal of immunological methods.
[40] Russell Higuchi,et al. Kinetic PCR Analysis: Real-time Monitoring of DNA Amplification Reactions , 1993, Bio/Technology.
[41] R. Riblet,et al. H-40, an antigen controlled by an Igh linked gene and recognized by cytotoxic T lymphocytes. I. Genetic analysis of H-40 and distribution of its product on B cell tumors , 1984, The Journal of experimental medicine.
[42] Eric J Kunkel,et al. Chemokines and the tissue-specific migration of lymphocytes. , 2002, Immunity.
[43] A. Zlotnik,et al. Recent advances in chemokines and chemokine receptors. , 1999, Critical reviews in immunology.
[44] W. Krenger,et al. Graft-versus-host disease and the Th1/Th2 paradigm , 1996, Immunologic research.